• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetically Modified Rabbits for Cardiovascular Research.用于心血管研究的转基因兔子
Front Genet. 2021 Feb 2;12:614379. doi: 10.3389/fgene.2021.614379. eCollection 2021.
2
Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis.基因工程高血脂和动脉粥样硬化模型仓鼠。
Methods Mol Biol. 2022;2419:433-459. doi: 10.1007/978-1-0716-1924-7_26.
3
Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.用于人类动脉粥样硬化研究的兔模型:从病理生理机制到转化医学
Pharmacol Ther. 2015 Feb;146:104-19. doi: 10.1016/j.pharmthera.2014.09.009. Epub 2014 Sep 30.
4
Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.缺乏低密度脂蛋白受体 (LDLR) 外显子 7 的兔自发性严重高胆固醇血症和动脉粥样硬化病变。
EBioMedicine. 2018 Oct;36:29-38. doi: 10.1016/j.ebiom.2018.09.020. Epub 2018 Sep 19.
5
Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis.用于动脉粥样硬化研究的胆固醇喂养兔模型和转基因兔模型。
J Atheroscler Thromb. 2000;7(1):26-32. doi: 10.5551/jat1994.7.26.
6
Gene Targeting in Rabbits: Single-Step Generation of Knock-out Rabbits by Microinjection of CRISPR/Cas9 Plasmids.兔基因打靶:通过显微注射CRISPR/Cas9质粒一步法生成基因敲除兔
Methods Mol Biol. 2017;1630:109-120. doi: 10.1007/978-1-4939-7128-2_10.
7
Principles and Applications of Rabbit Models for Atherosclerosis Research.兔动脉粥样硬化模型的原理与应用。
J Atheroscler Thromb. 2018 Mar 1;25(3):213-220. doi: 10.5551/jat.RV17018. Epub 2017 Oct 19.
8
Transgenic rabbit models for cardiac disease research.用于心脏病研究的转基因兔模型。
Br J Pharmacol. 2022 Mar;179(5):938-957. doi: 10.1111/bph.15484. Epub 2021 May 10.
9
The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.转基因兔作为人类疾病模型和生物活性重组蛋白的来源。
Transgenic Res. 2003 Oct;12(5):541-53. doi: 10.1023/a:1025816809372.
10
CRISPR/Cas9-Assisted Genome Editing in Murine Embryonic Stem Cells.CRISPR/Cas9辅助的小鼠胚胎干细胞基因组编辑
Methods Mol Biol. 2019;1960:1-21. doi: 10.1007/978-1-4939-9167-9_1.

引用本文的文献

1
Beyond the Mouse: The Mouse Lemur as a New Primate Model for Cardiovascular Research.超越小鼠:小鼠狐猴作为心血管研究的新型灵长类动物模型
Curr Cardiol Rep. 2025 Aug 13;27(1):123. doi: 10.1007/s11886-025-02276-x.
2
Apigenin attenuates the atherosclerotic lesions through enhancing selective autophagy/lipophagy and promoting RCT process.芹菜素通过增强选择性自噬/脂质自噬和促进逆向胆固醇转运过程来减轻动脉粥样硬化病变。
Pharm Biol. 2025 Dec;63(1):387-401. doi: 10.1080/13880209.2025.2509020. Epub 2025 May 23.
3
Non-rodent Models of Atherosclerosis: Repurposing of Existing Drugs and Search for Novel Treatment Strategies.动脉粥样硬化的非啮齿动物模型:现有药物的重新利用及新型治疗策略的探索
Curr Cardiol Rev. 2025;21(1):e1573403X316529. doi: 10.2174/011573403X316529240919103119.
4
Integrating Computational and Biological Hemodynamic Approaches to Improve Modeling of Atherosclerotic Arteries.整合计算和生物学血流动力学方法,改进动脉粥样硬化血管建模。
Adv Sci (Weinh). 2024 Jul;11(26):e2307627. doi: 10.1002/advs.202307627. Epub 2024 May 5.
5
Genome-edited rabbits: Unleashing the potential of a promising experimental animal model across diverse diseases.基因组编辑兔:在多种疾病中释放有前途的实验动物模型的潜力。
Zool Res. 2024 Mar 18;45(2):253-262. doi: 10.24272/j.issn.2095-8137.2023.201.
6
Pyroptosis in cardiovascular diseases: Pumping gasdermin on the fire.细胞焦亡在心血管疾病中的作用:gasdermin 为火上浇油。
Semin Immunol. 2023 Sep;69:101809. doi: 10.1016/j.smim.2023.101809. Epub 2023 Jul 19.
7
Somatic Cell Nuclear Transfer in Rabbits.兔体细胞核移植。
Methods Mol Biol. 2023;2647:169-181. doi: 10.1007/978-1-0716-3064-8_8.
8
Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.非小鼠动脉粥样硬化模型:探索新疗法转化潜力的方法。
Int J Mol Sci. 2022 Oct 26;23(21):12964. doi: 10.3390/ijms232112964.
9
Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications.CRISPR/Cas 在动脉粥样硬化中的应用潜力:疾病建模与治疗应用。
Int J Mol Sci. 2021 Aug 5;22(16):8422. doi: 10.3390/ijms22168422.

本文引用的文献

1
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits.人载脂蛋白A-II可减轻转基因兔的动脉粥样硬化。
Atherosclerosis. 2021 Jan;316:32-40. doi: 10.1016/j.atherosclerosis.2020.11.028. Epub 2020 Nov 28.
2
Genome engineering technologies in rabbits.兔基因组工程技术
J Biomed Res. 2020 Jun 12;35(2):135-147. doi: 10.7555/JBR.34.20190133.
3
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.载脂蛋白 CIII 缺乏可预防敲除兔动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2095-2107. doi: 10.1161/ATVBAHA.120.314368. Epub 2020 Aug 6.
4
Endothelial Lipase Exerts its Anti-Atherogenic Effect through Increased Catabolism of β-VLDLs.内皮脂肪酶通过增加β-VLDL 的代谢分解发挥抗动脉粥样硬化作用。
J Atheroscler Thromb. 2021 Feb 1;28(2):157-168. doi: 10.5551/jat.55244. Epub 2020 May 23.
5
Rabbit models of heart disease.心脏病的兔子模型。
Drug Discov Today Dis Models. 2008 Fall;5(3):185-193. doi: 10.1016/j.ddmod.2009.02.001. Epub 2009 Mar 17.
6
Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.巨噬细胞衍生的 MMP-9 增强了转基因兔动脉粥样硬化病变和血管钙化的进展。
J Cell Mol Med. 2020 Apr;24(7):4261-4274. doi: 10.1111/jcmm.15087. Epub 2020 Mar 3.
7
Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.使用 SpCas9-NG 在兔体内进行高效碱基编辑,靶向范围扩大。
FASEB J. 2020 Jan;34(1):588-596. doi: 10.1096/fj.201901587R. Epub 2019 Nov 26.
8
Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.通过CRISPR/Cas9技术对兔子体内葡萄糖激酶的一个短片段进行基因缺失,导致出现高血糖以及其他在MODY-2中可见的典型特征。
Cell Mol Life Sci. 2020 Aug;77(16):3265-3277. doi: 10.1007/s00018-019-03354-4. Epub 2019 Nov 13.
9
A Novel Pale-Yellow Coat Color of Rabbits Generated Mutation With CRISPR/Cas9 System.利用CRISPR/Cas9系统产生的一种新型浅黄色兔毛色突变体。
Front Genet. 2019 Sep 18;10:875. doi: 10.3389/fgene.2019.00875. eCollection 2019.
10
Site-specific integration of rotavirus VP6 gene in rabbit β-casein locus by CRISPR/Cas9 system.CRISPR/Cas9 系统介导轮状病毒 VP6 基因在兔 β-酪蛋白基因座的定点整合。
In Vitro Cell Dev Biol Anim. 2019 Sep;55(8):586-597. doi: 10.1007/s11626-019-00382-z. Epub 2019 Jul 31.

用于心血管研究的转基因兔子

Genetically Modified Rabbits for Cardiovascular Research.

作者信息

Fan Jianglin, Wang Yanli, Chen Y Eugene

机构信息

Department of Pathology, Xi'an Medical University, Xi'an, China.

Department of Molecular Pathology, Faculty of Medicine, Graduate School of Interdisciplinary Research, University of Yamanashi, Yamanashi, Japan.

出版信息

Front Genet. 2021 Feb 2;12:614379. doi: 10.3389/fgene.2021.614379. eCollection 2021.

DOI:10.3389/fgene.2021.614379
PMID:33603774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7885269/
Abstract

Rabbits are one of the most used experimental animals for investigating the mechanisms of human cardiovascular disease and lipid metabolism because they are phylogenetically closer to human than rodents (mice and rats). Cholesterol-fed wild-type rabbits were first used to study human atherosclerosis more than 100 years ago and are still playing an important role in cardiovascular research. Furthermore, transgenic rabbits generated by pronuclear microinjection provided another means to investigate many gene functions associated with human disease. Because of the lack of both rabbit embryonic stem cells and the genome information, for a long time, it has been a dream for scientists to obtain knockout rabbits generated by homologous recombination-based genomic manipulation as in mice. This obstacle has greatly hampered using genetically modified rabbits to disclose the molecular mechanisms of many human diseases. The advent of genome editing technologies has dramatically extended the applications of experimental animals including rabbits. In this review, we will update genetically modified rabbits, including transgenic, knock-out, and knock-in rabbits during the past decades regarding their use in cardiovascular research and point out the perspectives in future.

摘要

兔子是研究人类心血管疾病机制和脂质代谢最常用的实验动物之一,因为在系统发育上它们比啮齿动物(小鼠和大鼠)更接近人类。100多年前,用高胆固醇饲料喂养的野生型兔子首次被用于研究人类动脉粥样硬化,并且至今仍在心血管研究中发挥着重要作用。此外,通过原核显微注射产生的转基因兔子为研究许多与人类疾病相关的基因功能提供了另一种手段。由于缺乏兔子胚胎干细胞和基因组信息,长期以来,科学家们一直梦想着像在小鼠中那样,通过基于同源重组的基因组操作获得基因敲除兔子。这一障碍极大地阻碍了利用基因工程改造的兔子来揭示许多人类疾病的分子机制。基因组编辑技术的出现极大地扩展了包括兔子在内的实验动物的应用。在这篇综述中,我们将更新过去几十年里基因工程改造的兔子,包括转基因兔、基因敲除兔和基因敲入兔在心血管研究中的应用情况,并指出未来的发展前景。